Ghent University Academic Bibliography

Journal Article
A1
open access

Comorbid chronic rhinosinusitis and asthma : shared risk factors and treatment implications : an EAACI Task Force Report

Sanna Toppila‐Salmi, Sietze Reitsma, Valérie Hox, Simon Gane, Philippe Gevaert (UGent) , Juan Maza‐Solano, Alma Helevä, Ida Sulku, Kaisa Santala, Iiris Kangasniemi, et al.

(2026) ALLERGY. 81(4). p.1000-1023

Add to list

Journal Article
A1
open access

Roads to remission : evolving treatment concepts in type 2 inflammatory diseases

Marek Lommatzsch, Katharina Blumchen, Lisa A. Beck, Jean Bousquet, Guy Brusselle (UGent) , Wytske J. Fokkens, Eckard Hamelmann, Susanne Lau, Hagen Ott, Oliver Pfaar, et al.

(2025) ECLINICALMEDICINE. 80.

Add to list

Journal Article
A1
open access

Improvement of the therapeutic management of allergic patients in Europe : an expert think tank's position paper on allergen immunotherapy

Oliver Pfaar, Maria Beatrice Bilò, Péter Csonka, Frédéric de Blay, Monika Gappa, Radoslaw Gawlik, Philippe Gevaert (UGent) , Susanne Halken, Valerie Hox, Jasper Kappen, et al.

(2025) WORLD ALLERGY ORGANIZATION JOURNAL. 18(10).

Add to list

Journal Article
A1
open access

Clinical benefits with 300 IR HDM SLIT tablet in Europeans with house dust mite allergic rhinitis : post hoc analysis of a large phase 3 trial

Oliver Pfaar, Frédéric De Blay, Giorgio Walter Canonica, Thomas B. Casale, Philippe Gevaert (UGent) , Peter Hellings (UGent) , Krzysztof Kowal, Giovanni Passalacqua, Miguel Tortajada-Girbés, Carmen Vidal, et al.

(2024) WORLD ALLERGY ORGANIZATION JOURNAL. 17(1).

Add to list

Miscellaneous

Professor Peter Valentin Tomazic, Graz, Austria

Ludger Klimek, Adam Chaker, Valérie Hox, Stefano Del Giacco, Philippe Gevaert (UGent) , Mohamed Shamji, Sanna Toppila Salmi, Patrizia Bonadonna, Jolanta Walusiak‐Skorupa, André Morreira, et al.

(2024) ALLERGY. 79(8). p.2311-2312

Add to list

European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposis

Philippe Gevaert (UGent) , Jarno De Craemer (UGent) , Claus Bachert (UGent) , Manon Blauwblomme (UGent) , Adam Chaker, Cemal Cingi, Peter Hellings (UGent) , Claire Hopkins, Valérie Hox, Wytske J. Fokkens, et al.

(2023) ALLERGY. 78(4). p.912-922

Add to list

Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient‐reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS‐24 and SINUS‐52 studies

Claus Bachert (UGent) , Anju T. Peters, Enrico Heffler, Joseph K. Han, Heidi Olze, Oliver Pfaar, Chien‐Chia Chuang, Raj Rout, Richa Attre, Ledia Goga, et al.

(2022) CLINICAL AND EXPERIMENTAL ALLERGY. 52(2). p.244-249

Add to list

Journal Article
A1
open access

ARIA 2019 care pathways for allergic rhinitis in the Kuwait health care system

Mona Al-Ahmad, Jasmina Nurkic, Claus Bachert (UGent) , Oliver Pfaar, Holger J. Schunemann, Wienczyslawa Czarlewski, Anna Bedbrook and Jean Bosquet

(2021) MEDICAL PRINCIPLES AND PRACTICE. 30(4). p.320-330

Add to list

A 300 IR sublingual tablet is an effective, safe treatment for house dust mite induced allergic rhinitis : an international, double-blind, placebo-controlled, randomized phase III clinical trial

Pascal Demoly, Jonathan Corren, Peter Creticos, Frederic De Blay, Philippe Gevaert (UGent) , Peter Hellings (UGent) , Krzysztof Kowal, Martine Le Gall, Natalia Nenasheva, Giovanni Passalacqua, et al.

(2021) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 147(3). p.1020-1030.e10

Add to list

A responder analysis to demonstrate Dupilumab treatment effect across objective and patient-reported subjective endpoints for patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP)

Claus Bachert (UGent) , Anju Peters, Enrico Heffler, Joseph Han, Heidi Olze, Oliver Pfaar, Chien-Chia Chuang, Raj Rout, Richa Attre, Ledia Goga, et al.

(2021) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 147(2). p.AB132-AB132

Academic Bibliography

Comorbid chronic rhinosinusitis and asthma : shared risk factors and treatment implications : an EAACI Task Force Report

Roads to remission : evolving treatment concepts in type 2 inflammatory diseases

Improvement of the therapeutic management of allergic patients in Europe : an expert think tank's position paper on allergen immunotherapy

Clinical benefits with 300 IR HDM SLIT tablet in Europeans with house dust mite allergic rhinitis : post hoc analysis of a large phase 3 trial

Professor Peter Valentin Tomazic, Graz, Austria

European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposis

Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient‐reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS‐24 and SINUS‐52 studies

ARIA 2019 care pathways for allergic rhinitis in the Kuwait health care system

A 300 IR sublingual tablet is an effective, safe treatment for house dust mite induced allergic rhinitis : an international, double-blind, placebo-controlled, randomized phase III clinical trial

A responder analysis to demonstrate Dupilumab treatment effect across objective and patient-reported subjective endpoints for patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP)

Contents

Support

Contact